Combination therapy for the management of hypertension: a review of the evidence

N Sood, KM Reinhart, WL Baker - American Journal of Health …, 2010 - academic.oup.com
Purpose Evidence regarding combination therapy for the management of hypertension is
reviewed. Summary Numerous clinical trials have demonstrated the importance of early …

Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice

M Volpe, G Tocci - Expert Review of Cardiovascular Therapy, 2010 - Taylor & Francis
Arterial hypertension is a very complex disease characterized by a sustained rise in systolic
and/or diastolic blood pressure (BP) levels and a significantly increased risk of developing …

Lack of impact of a comprehensive intervention on hypertension in the primary care setting

TJ Niiranen, K Leino, P Puukka, I Kantola… - American journal of …, 2014 - academic.oup.com
BACKGROUND The implementation of lifestyle modifications, home blood pressure (BP)
measurement, and optimization of antihypertensive drug therapy have been shown to …

Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy

SH Hong, J Wang, J Tang - American journal of hypertension, 2013 - academic.oup.com
BACKGROUND The use of fixed-dose combinations (FDCs) has been increasing since the
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and …

Objective for 2015: 70% of treated and controlled hypertensive patients. Seven key points to reach this goal in practice. A joint call for action of the French League …

JJ Mourad, X Girerd - Journal des maladies vasculaires, 2012 - Elsevier
For the past 50 years, the implementation of therapeutic advances to the largest number of
people has made it possible to have an exemplary reduction in cardiovascular mortality …

Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

CP Lin, YC Tung, FC Hsiao, CH Yang… - The Journal of …, 2020 - Wiley Online Library
Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent …

Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of β-blockade

MS Arnaout, W Almahmeed, M Ibrahim… - … medical research and …, 2011 - Taylor & Francis
Background: The prevalence and clinical consequences of hypertension in countries in
Africa and the Middle East have not been studied as well as in other regions. Scope: We …

Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection

B Waeber, F Feihl, LM Ruilope - Drugs, 2009 - Springer
Recent guidelines recommend initiation of antihypertensive therapy with fixed-dose
combinations in high-risk patients because such patients usually need two or more blood …

Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study

S Gadzhanova, J Ilomäki, EE Roughead - International journal of clinical …, 2013 - Springer
Abstract Background National guidelines in Australia advise that patients should be
stabilised on both individual antihypertensive medicines before initiating a fixed-dose …

Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine

G Tocci, F Palano, E Pagannone, D Chin… - Expert Review of …, 2009 - Taylor & Francis
Recent hypertension guidelines have highlighted the need to achieve blood pressure
control in order to effectively reduce cardiovascular and renal morbidity and mortality …